Dedicated to the acceptance, medical treatment, & legal protection of individuals in the process of correcting the misalignment of their anatomical sex, & supporting their transition into society.
London, UK. To reinvigorate medicine and provide a useful information tool for clinicians and patients
Why would anybody want to publish a journal that is a mountain of case reports? Aren't case...
London, UK. A journal that wants to accept not reject and to include patients as authors as much as possible
Cases Journal will publish any case report that is authentic, understandable, and ethical....
Rochester, MN, USA. Are the health needs of women adequately addressed by medical research as it is currently conducted? Researchers say a growing body of evidence shows important differences between men and w...
Berkeley, CA, USA. Standard magnetic resonance imaging (MRI) has found increasing usefulness for research and acceptance as a diagnostic tool, but it cannot meet the more stringent requirements of current need...
Paris, France. So here we are in the 21st century still trying to decipher a busy physician's handwriting and ensure that drug prescriptions do not have errors. The number of medical codes in common use among ...
Paris, France. How frequently do doctors misdiagnose patients? The issue of diagnostic error is rarely discussed and often understudied. While research has demonstrated that the great majority of medical diagn...
Chicago, IL, USA. The Journal of the American Medical Association (JAMA) has published studies in the April 15 (2008) issue that document the apparent misrepresentation of research data by one company and its manipulation of clinical research articles and clinical reviews. In an April 16th JAMA editorial, Catherine D. DeAngelis, M.D., M.P.H., Editor in Chief, and Phil B. Fontanarosa, M.D., M.B.A., Executive Deputy Editor, JAMA, provide comment on the studies.
"What are the lessons from the 2 articles in this issue of JAMA, from other publications that have examined related issues, and from extensive experience with how clinical research has been manipulated by for-profit companies?"
Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence. Catherine D. DeAngelis; Phil B. Fontanarosa. JAMA. 2008;299(15):1833-1835.
First, manipulation of studies and misrepresentation of study results could not occur without the cooperation (active and tacit) of clinical researchers, other authors, journal editors, peer reviewers, and the Food and Drug Administration (FDA).
Second, public trust for clinical research is in great jeopardy especially when the extent of how widespread such practices have become is unknown. Although we truly believe that the vast majority of researchers and other authors are honest and have the highest scientific integrity, manipulation of studies and publications by the pharmaceutical and medical device industries is either increasing or there has been more exposure of these practices.
Third, in addition to clinical research, clinical practice and medical education also are greatly influenced by for-profit companies. Drastic action is essential, and cooperation of everyone involved in medical research, medical editing, medical education, and clinical practice is required for meaningful change to occur.
Drs. DeAngelis and Fontanarosa propose the following:
All clinical trials must be prospectively listed in registries accepted by the International Committee of Medical Journal Editors (ICMJE) prior to patient enrollment, and the name(s) of the principal investigator(s) should be included as a required data element in the trial registration record.
All individuals named as authors on articles must fulfill authorship criteria. Journals should require each author to report his or her specific contributions to the article, and should consider publishing these contributions.
All journals must disclose all pertinent relationships of all authors with any for-profit companies, and must publish all funding sources for each article.
Journal editors must seriously consider funding sources and authors' disclosed financial conflicts of interest and financial relationships when deciding whether to publish a study or review.
For-profit companies that sponsor biomedical research studies should not be solely or primarily involved in collecting and monitoring of data, in conducting the data analysis, and in preparing the manuscript reporting study results.
All journals must require a statistical analysis of clinical trial data conducted by a statistician who is not an employee of a for-profit company.
Any author who fails to disclose financial relationships or other conflicts of interest, or who allows his or her name to be used for work that he or she did not actually perform, must be reported to the appropriate authority (i.e., medical school dean or department chair) or appropriate oversight body.
Any peer reviewer who provides any confidential information, such as a manuscript under review, to any third parties, such as for-profit companies, or who engages in other similar unethical behavior, also should be reported to the appropriate authority (e.g., medical school dean) or oversight body, and should be banned from reviewing and publishing articles in that journal.
Any editor who knowingly allows (or is party to allowing) for-profit companies to manipulate his or her journal must be relieved of the editorship.
To maintain a healthy distance from industry influence, professional organizations and providers of continuing medical education courses should not condone or tolerate for-profit companies having any input into the content of educational materials or providing funding or sponsorship for medical education programs.
Individual physicians must be free of financial influences of pharmaceutical and medical device companies including serving on speaker's bureaus or accepting gifts.
"When integrity in medical science or practice is impugned or threatened--such as by the influence of industry — patients, clinicians, and researchers are all at risk for harm, and public trust in research is jeopardized. Ensuring, maintaining, and strengthening the integrity of medical science must be a priority for everyone," they conclude.
Dr DeAngelis is Editor in Chief and Dr Fontanarosa is Executive Deputy Editor, JAMA.
Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence. Catherine D. DeAngelis; Phil B. Fontanarosa. JAMA. 2008;299(15):1833-1835.
Extract. The profession of medicine, in every aspect — clinical, education, and research—has been inundated with profound influence from the pharmaceutical and medical device industries. This has occurred because physicians have allowed it to happen, and it is time to stop.
Two articles in this issue of JAMA provide a glimpse of one company's apparent misrepresentation of research data and its manipulation of clinical research articles and clinical reviews; such information and articles influence the education and clinical practice of physicians and other health professionals. The direct influence of for-profit companies on education and clinical practice has been well documented, so this Editorial deals primarily with clinical research.
The articles by Ross and colleagues and by Psaty and Kronmal document how one company, Merck & Co Inc., apparently manipulated dozens of publications to promote one of its products. But make no mistake — the manipulation …
The TS-Si News Service is a collaborative effort by TS-Si.org editors, contributors, and corresponding institutions. The sources can include the cited individuals and organizations, as well as TS-Si.org staff contributions. Articles and news reports do not necessarily convey official positions of TS-Si, its partners, or affiliates.
We welcome your comments. Use the form below to leave a public comment or send private correspondence via the TS-Si Contact Page. We will not divulge any personal details or place you on a mailing list without your permission.
Robot Violinist. A robot plays Pomp and Circumstance on the violin. The robot used its mechanical fingers to push the strings and bowed with its other arm.
The 152 cm (five foot) performer can perform a variety of tasks with its hands and arms, each of which has 17 joints.
Using precise control and coordination to achieve human-like agility, the robot could also be used to assist with domestic duties or nursing and medical care.
Subscribe to this comment's feed
Show/Hide comments
Show/Hide comment form
Copyright © 2005-2008 TS-Si, Inc. • Except where noted, this site is licensed under a Creative Commons Attribution-NoDerivs 2.5 License. • Some rights reserved. • TS-Si is a nonprofit organization dedicated to the acceptance, medical treatment, & legal protection of individuals in the process of correcting the misalignment of their anatomical sex, & supporting their transition into society.